CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
Sculptra® +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01422538
NCT01422538N/ACompleted
CompareCT.gov

Evaluation of the Ulthera® System for Lifting and Tightening the Face and Neck Following Sculptra® Treatment

Ulthera, Inc·interventional·Posted Aug 24, 2011·Updated Dec 13, 2017

In Brief

A clinical study evaluating Ulthera® System, Sculptra®, and 1 other intervention for Skin Laxity. Completed, enrolled 30 participants across 1 site.

Detailed Summary

This clinical trial will evaluate clinical outcomes associated with the non-invasive Ultherapy™ treatment to improve skin laxity and tightening following a Sculptra® treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSkin Laxity
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedAug 24, 2011
Enrollment StartMay 1, 2011
Primary CompletionJun 1, 2012
Study CompletionSep 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 14.9 years ago

Interventions

Ulthera® Systemdevice

Focused ultrasound energy delivered below the surface of the skin on the lower face.

Sculptra®drug

Injectable filler reconstituted prior to use. Injections are administered to the lower face in a combination of cross-hatching and fanning techniques. The Sculptra is injected in two treatment sessions 6 weeks apart.

Sculptra® treatment followed by Ultherapy™ treatmentother

Sculptra® administered in 2 injection sessions 6 weeks apart, then Ultherapy™ treatment 4 months following Sculptra.